Amphotericin B lipid complex (ABLC) for the treatment of confirmed or presumed fungal infections in immunocompromised patients with hematologic malignancies

被引:59
作者
Mehta, J
Kelsey, S
Chu, P
Powles, R
Hazel, D
Riley, U
Evans, C
Newland, A
Treleaven, J
Singhal, S
机构
[1] ROYAL MARSDEN HOSP,SURREY,ENGLAND
[2] ROYAL LONDON HOSP,LONDON E1 1BB,ENGLAND
[3] ROYAL LIVERPOOL UNIV HOSP,LIVERPOOL,MERSEYSIDE,ENGLAND
关键词
abelcet; amphotericin B; amphotericin B lipid complex; aspergillosis; candidiasis; fungal infection;
D O I
10.1038/sj.bmt.1700842
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Sixty-four adult patients (median age 43) with hematologic malignancies who were immunocompromised after allogeneic (n = 23) or autologous (n = 9) blood/marrow transplantation, or chemotherapy (n = 32) received 68 courses of amphotericin B lipid complex (ABLC, Abelcet) at the daily dose of 5 mg/kg for presumed (n = 52) or proven (n = 16) fungal infection, The major indications for ABLC were failure of previous antifungal therapy and/or renal dysfunction, Fifty-three treatment courses in 49 patients comprising 4-58 doses (median 10) were considered evaluable, Fourteen courses administered for confirmed infections resulted in nine complete and one partial responses, and four failures (71% response), Thirty-nine empiric courses resulted in 18 complete and six partial responses, and 14 failures (64% response), The overall response rate was 66%, Five of seven evaluable patients with aspergillus pneumonia responded, Response rates were comparable for chemotherapy, autograft and allograft recipients, The change in serum creatinine from the beginning to the end of therapy was -284 to +277 mu mol/l (median +24), The creatinine doubled during seven evaluable courses of therapy, five of which were associated with concomitant nephrotoxic therapy, Nephrotoxicity was comparable for transplant and chemotherapy patients, Renal dysfunction necessitated discontinuation of ABLC in only four patients, These data suggest that ABLC is effective in presumed or confirmed fungal infections in immunocompromised patients after transplantation or chemotherapy.
引用
收藏
页码:39 / 43
页数:5
相关论文
共 20 条
[1]  
[Anonymous], 35 INT C ANT AG CHEM
[2]   REGIMEN-RELATED TOXICITY AND EARLY POSTTRANSPLANT SURVIVAL IN PATIENTS UNDERGOING MARROW TRANSPLANTATION FOR LYMPHOMA [J].
BEARMAN, SI ;
APPELBAUM, FR ;
BACK, A ;
PETERSEN, FB ;
BUCKNER, CD ;
SULLIVAN, KM ;
SCHOCH, HG ;
FISHER, LD ;
THOMAS, ED .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) :1288-1294
[3]  
BODEY GP, 1994, CANCER-AM CANCER SOC, V73, P2099, DOI 10.1002/1097-0142(19940415)73:8&lt
[4]  
2099::AID-CNCR2820730814&gt
[5]  
3.0.CO
[6]  
2-N
[7]  
BOWLER WA, 1992, INFECT MED, V9, P17
[8]   The use of amphotericin B lipid complex [J].
Franklin, IM ;
Mehta, J ;
Root, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (02) :288-290
[9]   Renal dysfunction following autologous bone marrow transplantation in adult patients with acute leukemia [J].
Glynne, P ;
Powles, R ;
Steele, J ;
Singhal, S ;
Treleaven, J ;
Tait, D ;
Mehta, J .
ACTA ONCOLOGICA, 1996, 35 (06) :709-712
[10]   CLINICAL-FEATURES AND ANALYSIS OF RISK-FACTORS FOR INVASIVE CANDIDAL INFECTION AFTER MARROW TRANSPLANTATION [J].
GOODRICH, JM ;
REED, EC ;
MORI, M ;
FISHER, LD ;
SKERRETT, S ;
DANDLIKER, PS ;
KLIS, B ;
COUNTS, GW ;
MEYERS, JD .
JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (04) :731-740